Anakinra treatment for refractory cerebral autoinflammatory responses
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51500
Abstract: Refractory cerebral autoinflammatory–autoimmune diseases are often associated with dysregulated innate immunity and are targeted by anakinra, an interleukin‐1 receptor antagonist. We analyzed the therapeutic effect of anakinra in refractory cerebral autoinflammatory response (CAIR) at a… read more here.
Keywords: autoinflammatory responses; anakinra treatment; refractory cerebral; cerebral autoinflammatory ... See more keywords
Cerebral autoinflammatory disease treated with anakinra
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.656
Abstract: Interest in autoimmune encephalitis has been growing since the discovery of various autoimmune antibodies, such as N‐methyl D‐aspartate receptors antibody and leucine‐rich glioma‐inactivated 1 antibody. However, in contrast to autoimmune encephalitis associated with dysregulated adaptive… read more here.
Keywords: disease treated; treated anakinra; autoinflammatory disease; cerebral autoinflammatory ... See more keywords